. 1997;52(2):203-23.

FDA implementation of standards developed by the International Conference on Harmonisation

P M Booth¹

Affiliations

P M Booth. Food Drug Law J. 1997.

. 1997;52(2):203-23.

P M Booth¹

No abstract available

Similar articles

International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2012 May 18;77(97):29665-6. Fed Regist. 2012. PMID: 22616137
International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2005 Apr 1;70(62):16827-8. Fed Regist. 2005. PMID: 15803631
International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2006 Jun 2;71(106):32105-6. Fed Regist. 2006. PMID: 16795933
International harmonisation of regulatory requirements.
Holmes M, Hill RE. Holmes M, et al. Rev Sci Tech. 2007 Aug;26(2):415-20. Rev Sci Tech. 2007. PMID: 17892161 Review.
Internationalization of regulatory requirements.
Juillet Y. Juillet Y. Fundam Clin Pharmacol. 2003 Feb;17(1):21-5. doi: 10.1046/j.1472-8206.2003.00118.x. Fundam Clin Pharmacol. 2003. PMID: 12588627 Review.

Ethical issues in tissue banking for research: the prospects and pitfalls of setting international standards.
Maschke KJ, Murray TH. Maschke KJ, et al. Theor Med Bioeth. 2004;25(2):143-55. doi: 10.1023/b:meta.0000033773.44765.7c. Theor Med Bioeth. 2004. PMID: 15368751 Review.